🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Glaucoma, Open-Angle

Preserflo MicroShunt Versus Trabeculectomy NCT07496957NA1 site📍 Bialystok Medical University of Bialystok · Tests: Preserflo MicroShunt Implantation, Trabeculectomy with MMC Vitamin Mix (B6, B9, B12, And Choline) For Glaucoma Patients NCT06885827NA2 sites📍 Stockholm📍 Stockholm Karolinska Institutet · Tests: Vitamin B-mix, Standard Care Long-Term Clinical Results of Ab-Interno Trabeculotomy in Glaucoma Management NCT07780916n/a1 site📍 Würzburg Wuerzburg University Hospital · Tests: Ab-interno trabeculotomy Evaluation of Microinvasive Glaucoma Surgery: MINIject® Versus Hydrus® Microstent in Combination With Cataract Surgery NCT06844292NA1 site📍 Graz Medical University of Graz · Tests: MINIject with Cataract Surgery, Hydrus Microstent with Cataract Surgery Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects NCT03870230NA1 site📍 Vienna Medical University of Vienna · Tests: Fourier Domain Doppler Optical Coherence Tomography (FDOCT), Dynamic Vessel Analyzer (DVA), Pattern Electroretinography… Multicenter Glaucoma Study Investigating Standalone Canaloplasty NCT05786196NA5 sites📍 Düsseldorf📍 Madrid📍 Edinburgh Nova Eye, Inc. · Tests: Ab-interno canaloplasty utilizing the iTrack Advance device, Ab-interno canaloplasty utilizing the OMNI Surgical System Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma NCT05696561NA3 sites📍 Santiago📍 San José📍 Santa Rosa de Copán New World Medical, Inc. · Tests: Canaloplasty Device Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension NCT07335211Phase 31 site📍 Seoul Huons Co., Ltd. · Tests: HUC3-637, HUC3-637-R Dresden Glaucoma and Treatment Study (DGTS) NCT02959242n/a1 site📍 Dresden Technische Universität Dresden Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions) NCT07290244Phase 14 sites📍 Glendale📍 Boston📍 New York Life Biosciences Inc. · Tests: ER-100 epigenetic therapy Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg NCT07400926n/a1 site📍 Kenosha Glaukos Corporation · Tests: Travoprost Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract NCT07462000NA2 sites📍 Warsaw📍 Warsaw Military Institute od Medicine National Research Institute · Tests: Phacoemulsification With Intraocular Lens Implantation and Deep Sclerectomy, Phacoemulsification With Intraocular Lens … Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt NCT06691555n/a1 site📍 Tbilisi Davinci LTD · Tests: Suprachoroidal silicone tube (SST) shunt Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea NCT07447011NA1 site📍 Giza Cairo University · Tests: lifetyle corrections and CPAP, CPAP Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma NCT05710198Phase 31 site📍 Milan Omikron Italia S.r.l. · Tests: Citicoline eye drops 2%, Placebo Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial NCT05405868Phase 310 sites📍 Belfast📍 Cambridge📍 East Grinstead University College, London · Tests: Nicotinomide, Matching placebo Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression NCT05940623NA1 site📍 Wong Chuk Hang The University of Hong Kong · Tests: Home IOP telemonitoring with smart phone-based intervention, Standard care and smart phone-based intervention Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. NCT05401357Phase 39 sites📍 Newport Beach📍 Petaluma📍 New Smyrna Beach Amneal Pharmaceuticals, LLC · Tests: Test - Bimatoprost 0.01% Ophthalmic Solution, Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution) Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults NCT04396002n/a1 site📍 Birmingham University of Alabama at Birmingham · Tests: Life Space Questionnaire, Low Luminance Questionnaire, Contrast sensitivity under dim illumination, Visual field under … Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma NCT07063537NA1 site📍 Halifax Nova Scotia Health Authority · Tests: Virtual Reality Visual Field (VR-VF) Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options NCT07303257n/a1 site📍 Lyon Hospices Civils de Lyon · Tests: NEI-VFQ-25 (National Eye Institute Visual Function Questionnaire-25). Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma NCT06057051NA1 site📍 Cincinnati Glaukos Corporation · Tests: iStent Infinite XEN Glaucoma Gel Stent Versus Trabeculectomy NCT05439161NA1 site📍 Salzburg Prof. Dr. Herbert Reitsamer · Tests: surgery Intraocular Pressure Measured by a Novel Sensing Contact Lens Versus Tonometry NCT04024293NA1 site📍 Lausanne Sensimed AG · Tests: Goldfish (GF) GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma NCT06921317Phase 1, Phase 21 site📍 Suzhou IVIEW Therapeutics Inc. · Tests: GVB-2001-high dose, GVB-2001-low dose Efficacy and Safety of iStent in Reducing Intraocular Pressure in Open-angle Glaucoma NCT07354009NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: PHACO+PC-IOL+iStent, PHACO+PC-IOL Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study NCT03921931NA1 site📍 Vienna Medical University of Vienna · Tests: White light stimulation Hydrus® Microstent New Enrollment Post-Approval Study NCT04553523NA22 sites📍 Irvine📍 Sacramento📍 Loveland Alcon Research · Tests: Hydrus Microstent, Cataract surgery, Monofocal IOL Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery NCT07036510Phase 1, Phase 21 site📍 Panama City EyeD Pharma · Tests: TimoD implant, Injector system, Timolol eye drops 0.5% Direct vs Standard SLT for Glaucoma: A Noninferiority Trial NCT07408154NA1 site📍 Charleston Medical University of South Carolina · Tests: Direct Selective laser Trabeculoplasty
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy